An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Tumor-derived extracellular vesicles (TEV) “educate” healthy cells to promote metastases. We found that melanoma TEV downregulated type I interferon (IFN) receptor and expression of IFN-inducible cholesterol 25-hydroxylase (CH25H). CH25H produces 25-hydroxycholesterol, which inhibited TEV uptake. Low CH25H levels in leukocytes from melanoma patients correlated with poor prognosis. Mice incapable of downregulating the IFN receptor and Ch25h were resistant to TEV uptake, TEV-induced pre-metastatic niche, and melanoma lung metastases; however, ablation of Ch25h reversed these phenotypes. An anti-hypertensive drug, reserpine, suppressed TEV uptake and disrupted TEV-induced formation of the pre-metastatic niche and melanoma lung metastases. These results suggest the importance of CH25H in defense against education of normal cells by TEV and argue for the use of reserpine in adjuvant melanoma therapy.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1878-3686
Volume Title
Publisher
Publisher DOI
Sponsorship
NHS Blood and Transplant (NHSBT) (WP15-02)
Wellcome Trust (101835/Z/13/Z)
Wellcome Trust (210688/Z/18/Z)